By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IsoRay, Inc. 

350 Hills Street
Suite 106
Richland  Washington  99354  U.S.A.
Phone: 509-375-1202 Fax:


Medical Device

Company News
IsoRay, Inc. (ISR)'s Cesium-131 Lung Cancer Treatment Reports 96% Success In Local Control And 100% Survival At 5 Years In High Risk Patients In Newly Published Report 5/21/2015 12:31:50 PM
IsoRay, Inc. (ISR) Reports Third Quarter Results 5/19/2015 1:21:32 PM
IsoRay, Inc. (ISR)'s Cesium-131 Cancer Treatment Takes Center Stage At Weill Cornell's International Symposium 5/12/2015 11:39:36 AM
IsoRay, Inc. (ISR)'s Cancer Fighting Isotope Cesium-131 Will Be Featured In Four Oral Presentations At American Brachytherapy Society Convention In Orlando, Florida 4/9/2015 9:29:20 AM
IsoRay, Inc. (ISR) Reports Second Quarter Results 2/20/2015 10:46:31 AM
IsoRay, Inc. (ISR)'s Cesium-131 Therapy Takes Center Stage At Russia's Neftyanik Hospital A Center Of Excellence Providing Cutting Edge Cancer Treatments 1/16/2015 11:02:36 AM
IsoRay, Inc. (ISR) Ranked 5th Highest Share Price Percentage Gainer (192%) In 2014 Among 2417 Companies Listed On The NYSE Group 1/13/2015 12:36:04 PM
IsoRay, Inc. (ISR)'s Cesium-131 Used In World's First Veterinary Implant In A Horse With Cancer 12/10/2014 11:17:14 AM
IsoRay, Inc. (ISR) Presents 'Striking' Brain Cancer Test Results; Stock Soars 12/1/2014 8:02:44 AM
IsoRay, Inc. (ISR) Announces Early Success For Young Peruvian Girl Utilizing Cesium-131 In First Stereotactic Implant For Inoperable Brain Cancer 10/7/2014 10:11:50 AM